Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia M Lappin

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Addiction (Abingdon, England)|October 22, 2024
Rare but relevant: Methamphetamine and Parkinson's diseaseJulia M Lappin
Experimental Neurology|June 24, 2021
Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A reviewJulia M Lappin, Shane Darke
Addiction (Abingdon, England)|July 20, 2019
Psychostimulant use and the brainJulia M Lappin, Grant E Sara
Journal of Neurology, Neurosurgery, and Psychiatry|August 25, 2017
Stroke and methamphetamine use in young adults: a reviewJulia M Lappin, Shane Darke, Michael Farrell
Drug and Alcohol Dependence|April 18, 2018
Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implicationsJulia M Lappin, Shane Darke, Michael Farrell
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 6, 2007
Risk factors for schizophrenia--all roads lead to dopamineMarta Di Forti, Julia M Lappin, Robin M Murray
Schizophrenia Bulletin|August 23, 2024
Experiencing Psychosis and Shame: A Systematic Review and Meta-analysis of the Strength and Patterns of AssociationKimberley Davies, Julia M Lappin, Chloe Gott, et al.
Maturitas|November 20, 2025
Women using menopausal hormone therapy who suicide have multiple risk factorsJulia M Lappin, Shane Darke, Sarah Grattan, et al.
The Australian and New Zealand Journal of Psychiatry|January 27, 2026
Shame and trauma are critical to understanding the impacts of psychosis: Examining clinical correlates within a tertiary psychosis service cohortKimberley Davies, Julia M Lappin, Sophie Isobel, et al.
Frontiers in Psychiatry|September 23, 2022
Underuse of recommended treatments among people living with treatment-resistant psychosisJulia M Lappin, Kimberley Davies, Maryanne O'Donnell, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Addiction (Abingdon, England)|October 22, 2024
Rare but relevant: Methamphetamine and Parkinson's diseaseJulia M Lappin
Experimental Neurology|June 24, 2021
Methamphetamine and heightened risk for early-onset stroke and Parkinson's disease: A reviewJulia M Lappin, Shane Darke
Addiction (Abingdon, England)|July 20, 2019
Psychostimulant use and the brainJulia M Lappin, Grant E Sara
Journal of Neurology, Neurosurgery, and Psychiatry|August 25, 2017
Stroke and methamphetamine use in young adults: a reviewJulia M Lappin, Shane Darke, Michael Farrell
Drug and Alcohol Dependence|April 18, 2018
Methamphetamine use and future risk for Parkinson's disease: Evidence and clinical implicationsJulia M Lappin, Shane Darke, Michael Farrell
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|March 6, 2007
Risk factors for schizophrenia--all roads lead to dopamineMarta Di Forti, Julia M Lappin, Robin M Murray
Schizophrenia Bulletin|August 23, 2024
Experiencing Psychosis and Shame: A Systematic Review and Meta-analysis of the Strength and Patterns of AssociationKimberley Davies, Julia M Lappin, Chloe Gott, et al.
Maturitas|November 20, 2025
Women using menopausal hormone therapy who suicide have multiple risk factorsJulia M Lappin, Shane Darke, Sarah Grattan, et al.
The Australian and New Zealand Journal of Psychiatry|January 27, 2026
Shame and trauma are critical to understanding the impacts of psychosis: Examining clinical correlates within a tertiary psychosis service cohortKimberley Davies, Julia M Lappin, Sophie Isobel, et al.
Frontiers in Psychiatry|September 23, 2022
Underuse of recommended treatments among people living with treatment-resistant psychosisJulia M Lappin, Kimberley Davies, Maryanne O'Donnell, et al.
Pageof 6